Cathie Wood predicts a forthcoming productivity boom driven by AI and emerging tech, despite short-term economic indicators ...

Cathie Wood foresees 7.3% GDP growth, while claiming the biggest productivity gains in history lie just ahead.

At the Advances in Genome Biology and Technology, AGBT, General Meeting, 10x Genomics (TXG) announced a series of new product innovations to solidify its position as the best partner for high ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...

Leerink Partners lowered 10x Genomics from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $25.00 to $12.00 in a research report on Thursday.

Try Now>> See the top stocks recommended by analysts >> Read More on TXG: 10x Genomics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Cathie Wood's ARK ETFs have disclosed their daily ... Additionally, ARK bought 78,752 shares of 10X Genomics Inc (NASDAQ:TXG) for a total of $1,122,216, reinforcing the fund's focus on life ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...

Cathie Wood’s ARK ETFs have disclosed their daily trades for ... Additionally, ARK bought 78,752 shares of 10X Genomics Inc (NASDAQ:TXG) for a total of $1,122,216, reinforcing the fund’s focus on life ...

Tempus AI As the ninth-largest holding in ARKK, with a 4.1% weight, Tempus AI is a holding worth keeping tabs on.The $10.5 billion mid-cap firm is a health tech firm that’s leveraging AI for use ...